Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (471-480 of 477) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 477 results.
Clinical and Experimental Rheumatology|January 17, 2012
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN)Brett D Thombs, Lisa R Jewett, Shervin Assassi, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.
Annals of the Rheumatic Diseases|October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis and Rheumatism|October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis Care & Research|September 5, 2023
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Patricia E Carreira, Madelon Vonk, et al.
American Journal of Human Genetics|January 7, 2014
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosisMaureen D Mayes, Lara Bossini-Castillo, Olga Gorlova, et al.
Pageof 48

Showing results (471-480 of 477) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 477 results.
Clinical and Experimental Rheumatology|January 17, 2012
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN)Brett D Thombs, Lisa R Jewett, Shervin Assassi, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.
Annals of the Rheumatic Diseases|October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis and Rheumatism|October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis Care & Research|September 5, 2023
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Patricia E Carreira, Madelon Vonk, et al.
American Journal of Human Genetics|January 7, 2014
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosisMaureen D Mayes, Lara Bossini-Castillo, Olga Gorlova, et al.
Pageof 48